I kliniske forsøg var bivirkninger, der blev rapporteret uanset forbindelse til forsøgslægemidlet, blødningsepisoder, oliguri, hyperpyrexi og luksation af led.
Adverse reactions irrespective of trial drug relationship reported during clinical trials were bleeding episodes, oliguria, hyperpyrexia and joint dislocation.